Table 1 Basic characteristics of the studies and quality of the data
First Author | Publication Year | Country | Study Design | Study Setting | Mean_age | Total Sample Size | Male | Female | Measurements | Sarcopenia (%) | JBI score |
|---|---|---|---|---|---|---|---|---|---|---|---|
Shuangling Xiu | 2021 | China | cross-sectional | Hospital-based | 68 | 582 | 291 | 291 | DXA | 9 | 8 |
Fuyuko Takahashi | 2021 | Japan | cross-sectional | Hospital-based | 69.4 | 369 | 206 | 163 | BIA | 7.9 | 7 |
Fuyuko Takahashi | 2021 | Japan | Prospective cohort study | Hospital-based | 71.3 | 396 | 232 | 164 | BIA | 14.6 | 7 |
Ken Sugimoto | 2021 | Japan | cross-sectional | Hospital-based | 70 | 588 | 346 | 242 | BIA | 6.3 | 6 |
Vata- V. Sundar | 2021 | Malaysia | Prospective observational study | Hospital-based | 60 | 50 | 37 | 13 | BIA | 64 | 8 |
Xiaofan Zhang | 2021 | China | cross-sectional | Hospital-based | 61 | 182 | 182 | 0 | DXA | 45.6 | 8 |
Fuyuko Takahashi | 2021 | Japan | cross-sectional | Hospital-based | 67.1 | 526 | 301 | 225 | BIA | 12.7 | 8 |
Hiroyasu Mori | 2021 | Japan | cross-sectional | Hospital-based | 65.4 | 645 | 390 | 255 | BIA | 11.8 | 8 |
Kentaro Mikura | 2022 | Japan | cross-sectional | Hospital-based | 67 | 261 | 153 | 108 | BIA | 19.9 | 7 |
Yoshitaka Hashimoto | 2022 | Japan | cross-sectional | Hospital-based | 71.6 | 239 | 140 | 99 | BIA | 15.9 | 8 |
Yoshihisa Hiromine | 2022 | Japan | cross-sectional | Hospital-based | 69.9 | 755 | 453 | 302 | BIA | 8.1 | 8 |
Kewei Wang | 2022 | China | cross-sectional | Hospital-based | 59.7 | 312 | 172 | 140 | DXA | 26.9 | 8 |
Sayani Das | 2023 | India | cross-sectional | community-based | 68.5 | 4126 | - | - | DXA | 22.6 | 8 |
Ming-Jun Chen | 2023 | China | cross-sectional | Hospital-based | 69.74 | 288 | 108 | 180 | BIA | 27.43 | 7 |
G.-C. Ma | 2023 | China | cross-sectional | Hospital-based | 65 | 280 | 111 | 169 | DXA | 15.36 | 8 |
Fuyuko Takahashi | 2023 | Japan | cross-sectional | Hospital-based | 69.1 | 266 | 162 | 104 | BIA | 18 | 8 |
Mijin Kim | 2023 | Korea | cross-sectional | community-based | 71 | 581 | 261 | 320 | BIA | 33.9 | 8 |
Lanyu Lu | 2023 | China | cross-sectional | Hospital-based | 70 | 223 | 100 | 123 | DXA | 36.3 | 8 |
Lei Fu | 2023 | China | cross-sectional | Hospital-based | 61.8 | 220 | 164 | 56 | DXA | 50 | 7 |
Lanyu Lu | 2023 | China | cross-sectional | Hospital-based | 64.45 | 385 | 167 | 218 | DXA | 32.2 | 8 |
Yu-Ting Hsu | 2023 | Taiwan | cross-sectional | Hospital-based | 67.3 | 110 | 46 | 64 | BIA | 37.3 | 8 |
Surapaneni Lakshmi Sravya | 2023 | India | cross-sectional | Hospital-based | 57.4 | 159 | 80 | 79 | DXA | 22 | 6 |
Hsin-Yen Yen | 2023 | Taiwan | cross-sectional | Hospital-based | 73.9 | 577 | 245 | 332 | BIA | 8.3 | 8 |
Yinghe Lin | 2023 | China | cross-sectional | community-based | 66 | 752 | 368 | 384 | DXA | 19.4 | 6 |
Wen Wei | 2023 | China | cross-sectional | Hospital-based | 57.8 | 153 | 91 | 62 | DXA | 24.2 | 8 |
Li- Sun | 2023 | China | cross-sectional | Hospital-based | 67.8 | 543 | 269 | 274 | DXA | 8.84 | 8 |
Ke Xu | 2024 | China | cross-sectional | Hospital-based | 60 | 678 | 447 | 231 | DXA | 17.4 | 7 |
Chun-hui Ji | 2024 | China | cross-sectional | community-based | 75 | 408 | 201 | 207 | BIA | 20.6 | 6 |
Yogesh M | 2024 | India | cross-sectional | Hospital-based | 55 | 404 | 220 | 184 | BIA | 45.3 | 6 |
Mingrui Zou | 2024 | China | cross-sectional | community-based | 67 | 783 | 412 | 371 | BIA | 9.2 | 8 |
Sohye Kim | 2024 | Korea | cross-sectional | community-based | 75 | 1586 | 721 | 865 | BIA | 37.1 | 8 |
Yang Sun | 2024 | China | cross-sectional | Hospital-based | 70.1 | 253 | 83 | 170 | DXA | 39.5 | 8 |
Li Quan | 2024 | China | cross-sectional | Hospital-based | 63.86 | 282 | 166 | 116 | BIA | 21.6 | 7 |
Yogesh M | 2024 | India | cross-sectional | community-based | 65.2 | 250 | 151 | 99 | BIA | 60.4 | 6 |
Satoshi Ida | 2024 | Japan | cross-sectional | Hospital-based | 75 | 510 | 310 | 200 | BIA | 16.4 | 8 |
Motoya Sato | 2024 | Japan | cross-sectional | Hospital-based | 80 | 112 | - | - | BIA | 48 | 8 |
Bingmei Hou | 2024 | China | cross-sectional | Hospital-based | 69.6 | 676 | 261 | 415 | DXA | 14.1 | 6 |
Rimesh Pal | 2024 | India | cross-sectional | Hospital-based | 64.2 | 129 | 0 | 129 | DXA | 27 | 8 |
Shiyue Zou | 2024 | China | cross-sectional | Hospital-based | 70 | 263 | - | - | BIA | 42.2 | 8 |